Newer classes of antidiabetes drugs: ophthalmological considerations for GLP-1R agonists, DPP-4 inhibitors, and SGLT-2 inhibitors.
作者信息
McReelis Kylen D, Lovshin Julie A
机构信息
Department of Ophthalmology and Vision Sciences, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
Division of Endocrinology and Metabolism, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
出版信息
Can J Ophthalmol. 2017 Nov;52 Suppl 1:S4-S7. doi: 10.1016/j.jcjo.2017.07.028. Epub 2017 Oct 4.
PMID:29074013
Abstract
摘要
Zotero 插件